BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,697 | -81.0% | 21,224 | +226.7% | 0.00% | -100.0% |
| Q3 2020 | $282,000 | +15.6% | 6,497 | -40.5% | 0.00% | 0.0% |
| Q1 2020 | $244,000 | +12.4% | 10,914 | -26.5% | 0.00% | 0.0% |
| Q4 2019 | $217,000 | +24.0% | 14,850 | -7.2% | 0.00% | 0.0% |
| Q2 2019 | $175,000 | -42.1% | 16,000 | -47.6% | 0.00% | 0.0% |
| Q1 2019 | $302,000 | +196.1% | 30,550 | +128.8% | 0.00% | – |
| Q3 2018 | $102,000 | – | 13,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |